To investigate L19-IL2 effects in a complex system that recapitulates the main tumor and immune cell components, we developed an immune-spheroid interaction platform with KPC06 and KPC12 and tumor-antigen cytotoxic T-lymphocytes (CTLs), as described in Agostini et al. [31]. The gene discussed is IL2; the disease is neoplasm.